These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 17330846
1. Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington County, MD. Gallicchio L, Visvanathan K, Burke A, Hoffman SC, Helzlsouer KJ. Int J Cancer; 2007 Jul 01; 121(1):211-15. PubMed ID: 17330846 [Abstract] [Full Text] [Related]
2. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK. J Natl Cancer Inst; 2005 Jun 01; 97(11):805-12. PubMed ID: 15928301 [Abstract] [Full Text] [Related]
3. Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study. Bardia A, Olson JE, Vachon CM, Lazovich D, Vierkant RA, Wang AH, Limburg PJ, Anderson KE, Cerhan JR. Breast Cancer Res Treat; 2011 Feb 01; 126(1):149-55. PubMed ID: 20669045 [Abstract] [Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study. Gierach GL, Lacey JV, Schatzkin A, Leitzmann MF, Richesson D, Hollenbeck AR, Brinton LA. Breast Cancer Res; 2008 Feb 01; 10(2):R38. PubMed ID: 18447943 [Abstract] [Full Text] [Related]
5. Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study. Friis S, Thomassen L, Sørensen HT, Tjønneland A, Overvad K, Cronin-Fenton DP, Vogel U, McLaughlin JK, Blot WJ, Olsen JH. Eur J Cancer Prev; 2008 Apr 01; 17(2):88-96. PubMed ID: 18287865 [Abstract] [Full Text] [Related]
6. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status. Bardia A, Hartmann LC, Vachon CM, Vierkant RA, Wang AH, Olson JE, Sellers TA, Cerhan JR. Arch Intern Med; 2008 Apr 01; 166(22):2478-83. PubMed ID: 17159013 [Abstract] [Full Text] [Related]
10. Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. Johnson TW, Anderson KE, Lazovich D, Folsom AR. Cancer Epidemiol Biomarkers Prev; 2002 Dec 01; 11(12):1586-91. PubMed ID: 12496048 [Abstract] [Full Text] [Related]
11. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study. Suzuki R, Iwasaki M, Inoue M, Sasazuki S, Sawada N, Yamaji T, Shimazu T, Tsugane S, Japan Public Health Center-based Prospective Study Group. Int J Cancer; 2011 Sep 01; 129(5):1214-24. PubMed ID: 21064092 [Abstract] [Full Text] [Related]
13. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A, Women's Health Initiative. Cancer Res; 2003 Sep 15; 63(18):6096-101. PubMed ID: 14522941 [Abstract] [Full Text] [Related]
16. Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings. Kirsh VA, Kreiger N, Cotterchio M, Sloan M, Theis B. Am J Epidemiol; 2007 Sep 15; 166(6):709-16. PubMed ID: 17660454 [Abstract] [Full Text] [Related]
17. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality. Bardia A, Ebbert JO, Vierkant RA, Limburg PJ, Anderson K, Wang AH, Olson JE, Vachon CM, Cerhan JR. J Natl Cancer Inst; 2007 Jun 06; 99(11):881-9. PubMed ID: 17551148 [Abstract] [Full Text] [Related]
18. NSAID use and breast cancer risk in the VITAL cohort. Ready A, Velicer CM, McTiernan A, White E. Breast Cancer Res Treat; 2008 Jun 06; 109(3):533-43. PubMed ID: 17674199 [Abstract] [Full Text] [Related]
19. Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort. Gill JK, Maskarinec G, Wilkens LR, Pike MC, Henderson BE, Kolonel LN. Am J Epidemiol; 2007 Nov 15; 166(10):1150-8. PubMed ID: 17698973 [Abstract] [Full Text] [Related]
20. Dietary cadmium exposure and risk of postmenopausal breast cancer: a population-based prospective cohort study. Julin B, Wolk A, Bergkvist L, Bottai M, Akesson A. Cancer Res; 2012 Mar 15; 72(6):1459-66. PubMed ID: 22422990 [Abstract] [Full Text] [Related] Page: [Next] [New Search]